A Roadmap to New Indications in Gastroenterology

A global pharmaceutical company wished to determine potential therapeutic opportunities for a subset of patients who experience severe complications around three types of chronic gastro illnesses.

To assess the landscape and opportunities for a new medical solution, we needed to identify whitespaces at the intersection of patient need, HCP need, and future shifts in gastro care.

Informed by this new understanding,  we confirmed for our client team the critical need for new treatment opportunities and key market opportunities in this space. This allowed them to meaningfully extend their existing leadership in the gastro space, and to prioritize initiatives throughout the treatment development process.